Heartware International Beats on the Top Line

Seth Jayson, The Motley Fool
Updated

Heartware International (NAS: HTWR) reported earnings on April 29. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), Heartware International crushed expectations on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded significantly. Non-GAAP loss per share contracted. GAAP loss per share contracted.


Margins grew across the board.

Revenue details
 Heartware International chalked up revenue of $49.5 million. The 16 analysts polled by S&P Capital IQ anticipated revenue of $39.9 million on the same basis. GAAP reported sales were 87% higher than the prior-year quarter's $26.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at -$0.87. The 16 earnings estimates compiled by S&P Capital IQ predicted -$1.22 per share. Non-GAAP EPS were -$0.87 for Q1 compared to -$1.33 per share for the prior-year quarter. GAAP EPS were -$0.03 for Q1 versus -$0.04 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 61.9%, 300 basis points better than the prior-year quarter. Operating margin was -16.6%, much better than the prior-year quarter. Net margin was -26.3%, much better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $49.7 million. On the bottom line, the average EPS estimate is -$0.75.

Next year's average estimate for revenue is $207.2 million. The average EPS estimate is -$3.15.

Investor sentiment
 The stock has a one-star rating (out of five) at Motley Fool CAPS, with 30 members out of 48 rating the stock outperform, and 18 members rating it underperform. Among 15 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 10 give Heartware International a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Heartware International is outperform, with an average price target of $96.93.

Is Heartware International the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

The article Heartware International Beats on the Top Line originally appeared on Fool.com.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement